[go: up one dir, main page]

NO20030585D0 - Bruk av triazintrionsulfoner for å bekjempe koksidiose - Google Patents

Bruk av triazintrionsulfoner for å bekjempe koksidiose

Info

Publication number
NO20030585D0
NO20030585D0 NO20030585A NO20030585A NO20030585D0 NO 20030585 D0 NO20030585 D0 NO 20030585D0 NO 20030585 A NO20030585 A NO 20030585A NO 20030585 A NO20030585 A NO 20030585A NO 20030585 D0 NO20030585 D0 NO 20030585D0
Authority
NO
Norway
Prior art keywords
trion
sulfones
triazine
coccidiosis
combat
Prior art date
Application number
NO20030585A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030585L (no
Inventor
Gisela Greif
Iris Bill
Hans-Christian Mundt
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20030585D0 publication Critical patent/NO20030585D0/no
Publication of NO20030585L publication Critical patent/NO20030585L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/30—Only oxygen atoms
    • C07D251/34—Cyanuric or isocyanuric esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20030585A 2000-08-17 2003-02-06 Bruk av triazintrionsulfoner for a bekjempe koksidiose NO20030585L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040174A DE10040174A1 (de) 2000-08-17 2000-08-17 Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
PCT/EP2001/009060 WO2002014288A1 (fr) 2000-08-17 2001-08-06 Utilisation de sulfones de triazinetrions pour lutter contre les coccidioses

Publications (2)

Publication Number Publication Date
NO20030585D0 true NO20030585D0 (no) 2003-02-06
NO20030585L NO20030585L (no) 2003-02-06

Family

ID=7652719

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030585A NO20030585L (no) 2000-08-17 2003-02-06 Bruk av triazintrionsulfoner for a bekjempe koksidiose

Country Status (23)

Country Link
US (1) US7915257B2 (fr)
EP (1) EP1311491A1 (fr)
JP (1) JP2004506624A (fr)
KR (1) KR100803078B1 (fr)
CN (3) CN101361743A (fr)
AR (1) AR030378A1 (fr)
AU (2) AU2001278522B2 (fr)
BR (1) BR0113268A (fr)
CA (1) CA2419471C (fr)
CZ (1) CZ300020B6 (fr)
DE (1) DE10040174A1 (fr)
HR (1) HRP20030194A2 (fr)
HU (1) HUP0303701A3 (fr)
MX (1) MXPA03001429A (fr)
MY (1) MY136518A (fr)
NO (1) NO20030585L (fr)
NZ (1) NZ524200A (fr)
PL (1) PL359709A1 (fr)
SK (1) SK1652003A3 (fr)
TW (1) TW200819431A (fr)
WO (1) WO2002014288A1 (fr)
YU (1) YU11703A (fr)
ZA (1) ZA200301225B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
SI22751A (sl) * 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
EP2740469A1 (fr) * 2012-12-07 2014-06-11 Ceva Sante Animale Nouveaux traitements avec des triazines
EP2740470A1 (fr) * 2012-12-07 2014-06-11 Ceva Sante Animale Traitement de la coccidiose avec des compositions de triazine intramusculaire
EP2740492A1 (fr) 2012-12-07 2014-06-11 Ceva Sante Animale Formulations de triazines avec un principe actif additionnel et tensioactif(s)
CN102973497A (zh) * 2012-12-13 2013-03-20 江苏恒丰强生物技术有限公司 一种托曲珠利溶液及其制备方法
PL3759088T3 (pl) 2018-02-26 2023-07-03 AlzeCure Pharma AB Pochodne triazyny do leczenia chorób związanych z neurotrofinami
EP3578181A1 (fr) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation destinée au traitement simultané d'infections coccidiennes et de déficiences en fer
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413722C3 (de) 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel
DE2414612A1 (de) 1974-03-26 1975-10-16 Bayer Ag 1-aryluracile, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2532363A1 (de) 1975-07-19 1977-02-03 Bayer Ag Substituierte 2-phenyl-1,2,4- triazin-3,5(2h,4h)-dione, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2718799A1 (de) * 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4255231A (en) * 1979-06-13 1981-03-10 Congoleum Corporation Carpet etching
DE3314739A1 (de) * 1983-04-23 1984-10-25 Bayer Ag, 5090 Leverkusen 1-(4-(4-(fluoralkylmethylthio- oder -sulfinyl- oder -sulfonyl-)phenoxy) phenyl)-1,3,5-triazin-2,4,6(1h,3h,5h)-trione, verfahren zu ihrer herstellung und ihre verwendung als coccidiosemittel
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
US4808404A (en) * 1988-01-11 1989-02-28 A. H. Robins Company, Inc. Live vaccine for coccidiosis utilizing coccidial sporozoites
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
WO2000019964A2 (fr) * 1998-10-08 2000-04-13 New Ace Research Company Nouvelles compositions et nouveaux procedes destines a la prevention et au traitement de maladies provoquees par des protozoaires
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
AU2198100A (en) * 1998-12-22 2000-07-12 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Also Published As

Publication number Publication date
ZA200301225B (en) 2004-02-16
TW200819431A (en) 2008-05-01
MY136518A (en) 2008-10-31
CN1469868A (zh) 2004-01-21
AU2001278522B2 (en) 2007-03-22
KR100803078B1 (ko) 2008-02-18
DE10040174A1 (de) 2002-02-28
US7915257B2 (en) 2011-03-29
AU7852201A (en) 2002-02-25
HUP0303701A3 (en) 2006-01-30
US20040013699A1 (en) 2004-01-22
HUP0303701A2 (hu) 2004-03-29
MXPA03001429A (es) 2004-05-04
KR20030017659A (ko) 2003-03-03
NZ524200A (en) 2005-02-25
AR030378A1 (es) 2003-08-20
CZ300020B6 (cs) 2009-01-14
CN1853635A (zh) 2006-11-01
YU11703A (sh) 2006-01-16
EP1311491A1 (fr) 2003-05-21
WO2002014288A1 (fr) 2002-02-21
HRP20030194A2 (en) 2005-10-31
NO20030585L (no) 2003-02-06
SK1652003A3 (en) 2004-02-03
AU2001278522B9 (en) 2002-02-25
CN101361743A (zh) 2009-02-11
JP2004506624A (ja) 2004-03-04
PL359709A1 (en) 2004-09-06
BR0113268A (pt) 2003-07-08
CA2419471C (fr) 2009-10-13
CA2419471A1 (fr) 2003-02-14

Similar Documents

Publication Publication Date Title
AU2002305756A8 (en) Use of nf-kappa-b inhibitors to treat dry eye disorders
ID30590A (id) Celana sekali pakai jenis-celana pendek
IL142113A0 (en) Use of glycogen phosphorylase inhibitors
NO20030585D0 (no) Bruk av triazintrionsulfoner for å bekjempe koksidiose
EP1365290A4 (fr) Composition de reserve
EP1302813A4 (fr) Composition de reserve
AU2001281309A1 (en) The use of c3-c5 monosaccharides to protect keratinous fibers
PT1250321E (pt) Composicao de gliburida
PT1296981E (pt) Derivados substituidos da pirrolopiridinona uteis como inibidores da fosfodiesterase
DE60111451D1 (de) Decklackzusammensetzung
DE60112916D1 (de) Kosmetische zusammensetzungen
DK1434507T3 (da) Forbedringer til seng-og-bord-kombinationsmöbel
MXPA01009951A (es) Composicion para aumentar permeacion de agentes topicos de la piel.
AU2001285325A1 (en) Use of threo-methylphenidate compounds to enhance memory
PL361733A1 (en) Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
AU2001278522A1 (en) Use of triazinetrione sulfones for combating coccidiosis
EE05444B1 (et) FSH kasutamine viljatuse raviks
AR028070A1 (es) Sintesis de compuestos de ciclohexendimetanol o ciclohexandimetanol
GB0012487D0 (en) Use of metal compounds to treat gastrointestinal infections
NO20031953L (no) Anvendelse av disazoforbindelser
AU7402201A (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2001261736A1 (en) Use of acrylamide copolymer to reduce stickies deposits
ITMI20011820A0 (it) Trattamento di ustioni
FI20002526A7 (fi) Pyridatsinonijohdannaisten uusi käyttö

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application